“EVALUATED EFFECTS OF THE TREATMENT WITH IMATINIB OF CHRONIC MYELOID LEUKEMIA PATIENTS WITH ADDITIONAL CYTOGENETIC ABNORMALITIES IN HEMATOLOGY AND BLOOD TRANSFUTION CENTER, BACHMAI HOSPITAL” (2026) Vietnam Journal of Community Medicine, 67(2). doi:10.52163/yhc.v67i2.4337.